NEW YORK (GenomeWeb) – Applied BioCode today said it has expanded an existing licensing and supply agreement with PerkinElmer for the use of Applied BioCode's Barcoded Magnetic Bead technology. 

The amended non-exclusive deal provides PerkinElmer access to Applied BioCode's 4,096-plex BMB patents, as well as the BioCode MDx 3000 high-throughput system for the Asian markets. PerkinElmer will develop market-specific multiplexed molecular diagnostics for infectious diseases for the BioCode MDx 3000 platform and distribute them into select Asian markets, Applied BioCode said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.